BBRI:IDXPT Bank Rakyat Indonesia (Persero) Tbk Class B Analysis
Data as of 2026-05-18 - not real-time
IDR 3,060.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Bank Rakyat Indonesia (BBRI) is trading at IDR 3,060, comfortably above its 30‑day support of IDR 2,980 but still below the 20‑day SMA of 3,156 and the 50‑day SMA of 3,358, signaling a short‑term bearish bias. Technical momentum shows a modest bullish MACD histogram (+6.85) and an RSI of 38, suggesting the stock is approaching oversold territory and could attract upside if buying pressure returns. The recent news that BBRI plans to grow its loan portfolio selectively at 7‑9% YoY and that it was the only large‑cap bank to post a 1.18% weekly gain (closing at IDR 3,430) adds a positive earnings‑growth narrative. Valuation metrics are compelling: a trailing P/E of 7.9 versus an industry average of 16.5, a P/B of 1.36 and an attractive dividend yield of 13.4% with an 88.8% payout ratio. However, the company reports a large negative operating cash flow and a 30‑day volatility of 35.6%, indicating earnings quality and price stability concerns.
Given the low beta (≈0.1) and strong liquidity (average 10‑day volume > 200 M shares), market‑wide systematic risk is muted, but the high drawdown of 32.8% and decreasing volume trend point to heightened downside risk if credit growth stalls. The dividend’s sustainability is questionable due to cash‑flow constraints, despite the generous payout. Overall, BBRI appears undervalued with a blend of value and income appeal, but investors should weigh the earnings‑quality risk against the upside potential from selective loan growth and market‑relative cheapness.
Given the low beta (≈0.1) and strong liquidity (average 10‑day volume > 200 M shares), market‑wide systematic risk is muted, but the high drawdown of 32.8% and decreasing volume trend point to heightened downside risk if credit growth stalls. The dividend’s sustainability is questionable due to cash‑flow constraints, despite the generous payout. Overall, BBRI appears undervalued with a blend of value and income appeal, but investors should weigh the earnings‑quality risk against the upside potential from selective loan growth and market‑relative cheapness.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near support with bullish MACD crossover
- RSI indicating oversold conditions
- Recent weekly outperformance among large‑cap banks
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued multiples relative to peers
- Targeted loan‑growth of 7‑9% YoY
- High dividend yield enhancing total return
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustained earnings‑quality concerns from negative operating cash flow
- Potential volatility from macro‑economic and credit‑risk factors
- Attractive valuation but need to monitor dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth16.30%
Profit Margin40.23%
P/E Ratio7.9
ROE18.14%
ROA2.71%
P/B Ratio1.4
Op. Cash FlowIDR-152577001914368
Industry P/E16.5
Technical Analysis
TrendBearish
RSI38.0
SupportIDR 2,980.00
ResistanceIDR 3,470.00
MA 20IDR 3,156.00
MA 50IDR 3,358.20
MA 200IDR 3,730.00
MACDBullish
VolumeDecreasing
Fear & Greed Index88.34
Valuation
Target PriceIDR 4,070.71
Upside/Downside33.03%
GradeUndervalued
TypeBlend
Dividend Yield13.40%
Risk Assessment
Beta0.10
Volatility35.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.